C5AR1 and non-small cell lung carcinoma: The PICO (Population, Intervention, Comparison, Outcome) framework guided the inclusion of studies involving NSCLC patients or human cell lines, reporting on C3a/C5a levels and their association with clinical outcomes or pro-tumoral effects.